Metabolic Disruptions in Parkinson's Uncover New Treatment Potential

A new study has revealed critical metabolic impairments in Parkinson's disease (PD), focusing on purine metabolism and ATP recycling. Researchers found that patients with PD have significantly lower levels of uric acid and other purine metabolites in their blood and cerebrospinal fluid, affecting energy production in the brain.